Report Detail
Global Intravenous Solutions Market Insights, Forecast to 2025
- RnM3036416 |
- 28 February, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.
The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.
Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.
USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.
The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Intravenous Solutions market is valued at 1710 million US$ in 2018 and will reach 1990 million US$ by the end of 2025, growing at a CAGR of 1.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous Solutions market based on company, product type, end user and key regions.
This report studies the global market size of Intravenous Solutions in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Solutions in these regions.
This research report categorizes the global Intravenous Solutions market by top players/brands, region, type and end user. This report also studies the global Intravenous Solutions market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science
Market size by Product
Crystalloids
Colloids
Others
Market size by End User
Basic IV Solutions
Nutrient Infusion Solution
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intravenous Solutions market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intravenous Solutions market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravenous Solutions companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intravenous Solutions submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intravenous Solutions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Solutions market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Intravenous Solutions Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Intravenous Solutions Market Size Growth Rate by Product
- 1.4.2 Crystalloids
- 1.4.3 Colloids
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Intravenous Solutions Market Size Growth Rate by End User
- 1.5.2 Basic IV Solutions
- 1.5.3 Nutrient Infusion Solution
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Intravenous Solutions Market Size
- 2.1.1 Global Intravenous Solutions Revenue 2014-2025
- 2.1.2 Global Intravenous Solutions Sales 2014-2025
- 2.2 Intravenous Solutions Growth Rate by Regions
- 2.2.1 Global Intravenous Solutions Sales by Regions
- 2.2.2 Global Intravenous Solutions Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Intravenous Solutions Sales by Manufacturers
- 3.1.1 Intravenous Solutions Sales by Manufacturers
- 3.1.2 Intravenous Solutions Sales Market Share by Manufacturers
- 3.1.3 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI)
- 3.2 Intravenous Solutions Revenue by Manufacturers
- 3.2.1 Intravenous Solutions Revenue by Manufacturers (2014-2019)
- 3.2.2 Intravenous Solutions Revenue Share by Manufacturers (2014-2019)
- 3.3 Intravenous Solutions Price by Manufacturers
- 3.4 Intravenous Solutions Manufacturing Base Distribution, Product Types
- 3.4.1 Intravenous Solutions Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Intravenous Solutions Product Type
- 3.4.3 Date of International Manufacturers Enter into Intravenous Solutions Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Intravenous Solutions Sales by Product
- 4.2 Global Intravenous Solutions Revenue by Product
- 4.3 Intravenous Solutions Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Intravenous Solutions Breakdown Data by End User
6 North America
- 6.1 North America Intravenous Solutions by Countries
- 6.1.1 North America Intravenous Solutions Sales by Countries
- 6.1.2 North America Intravenous Solutions Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Intravenous Solutions by Product
- 6.3 North America Intravenous Solutions by End User
7 Europe
- 7.1 Europe Intravenous Solutions by Countries
- 7.1.1 Europe Intravenous Solutions Sales by Countries
- 7.1.2 Europe Intravenous Solutions Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Intravenous Solutions by Product
- 7.3 Europe Intravenous Solutions by End User
8 Asia Pacific
- 8.1 Asia Pacific Intravenous Solutions by Countries
- 8.1.1 Asia Pacific Intravenous Solutions Sales by Countries
- 8.1.2 Asia Pacific Intravenous Solutions Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Intravenous Solutions by Product
- 8.3 Asia Pacific Intravenous Solutions by End User
9 Central & South America
- 9.1 Central & South America Intravenous Solutions by Countries
- 9.1.1 Central & South America Intravenous Solutions Sales by Countries
- 9.1.2 Central & South America Intravenous Solutions Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Intravenous Solutions by Product
- 9.3 Central & South America Intravenous Solutions by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Intravenous Solutions by Countries
- 10.1.1 Middle East and Africa Intravenous Solutions Sales by Countries
- 10.1.2 Middle East and Africa Intravenous Solutions Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Intravenous Solutions by Product
- 10.3 Middle East and Africa Intravenous Solutions by End User
11 Company Profiles
- 11.1 Baxter
- 11.1.1 Baxter Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Baxter Intravenous Solutions Products Offered
- 11.1.5 Baxter Recent Development
- 11.2 Hospira
- 11.2.1 Hospira Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Hospira Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Hospira Intravenous Solutions Products Offered
- 11.2.5 Hospira Recent Development
- 11.3 B. Braun Melsungen
- 11.3.1 B. Braun Melsungen Company Details
- 11.3.2 Company Business Overview
- 11.3.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 B. Braun Melsungen Intravenous Solutions Products Offered
- 11.3.5 B. Braun Melsungen Recent Development
- 11.4 Fresenius Kabi
- 11.4.1 Fresenius Kabi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Fresenius Kabi Intravenous Solutions Products Offered
- 11.4.5 Fresenius Kabi Recent Development
- 11.5 Claris Lifesciences
- 11.5.1 Claris Lifesciences Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Claris Lifesciences Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Claris Lifesciences Intravenous Solutions Products Offered
- 11.5.5 Claris Lifesciences Recent Development
- 11.6 Grifols
- 11.6.1 Grifols Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Grifols Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Grifols Intravenous Solutions Products Offered
- 11.6.5 Grifols Recent Development
- 11.7 Vifor Pharma
- 11.7.1 Vifor Pharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Vifor Pharma Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Vifor Pharma Intravenous Solutions Products Offered
- 11.7.5 Vifor Pharma Recent Development
- 11.8 JW Life Science
- 11.8.1 JW Life Science Company Details
- 11.8.2 Company Business Overview
- 11.8.3 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 JW Life Science Intravenous Solutions Products Offered
- 11.8.5 JW Life Science Recent Development
12 Future Forecast
- 12.1 Intravenous Solutions Market Forecast by Regions
- 12.1.1 Global Intravenous Solutions Sales Forecast by Regions 2019-2025
- 12.1.2 Global Intravenous Solutions Revenue Forecast by Regions 2019-2025
- 12.2 Intravenous Solutions Market Forecast by Product
- 12.2.1 Global Intravenous Solutions Sales Forecast by Product 2019-2025
- 12.2.2 Global Intravenous Solutions Revenue Forecast by Product 2019-2025
- 12.3 Intravenous Solutions Market Forecast by End User
- 12.4 North America Intravenous Solutions Forecast
- 12.5 Europe Intravenous Solutions Forecast
- 12.6 Asia Pacific Intravenous Solutions Forecast
- 12.7 Central & South America Intravenous Solutions Forecast
- 12.8 Middle East and Africa Intravenous Solutions Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Intravenous Solutions Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Intravenous Solutions . Industry analysis & Market Report on Intravenous Solutions is a syndicated market report, published as Global Intravenous Solutions Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Intravenous Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
